Global Cancer Gene Therapy Market: Cancer gene therapy is a process that treats cancers by inserting therapeutic DNA into the patient. Cancer gene therapy is gaining popularity as a result of its success rate in preclinical and clinical trial stages. The most common technique for cancer gene therapy involves replacing a mutated gene that is causing cancer with a healthy copy of the gene. A new technique that is being used to fight cancer cells.
Globally, rising cancer prevalence wants to increase demand for gene therapy as the effective personalized treatment choice. Various factors, such as the increase in the prevalence of cancer, rising government initiatives, increase in funding from various government and non-government organizations, ethical acceptance of gene therapy for the treatment of diseases and growing popularity of DNA vaccines is driving the global cancer gene therapy market. However, less awareness and high-cost treatment are involved in the treatment of cancer.
A sample of this report is available upon request @
The Global cancer gene therapy market is segmented on the basis of type, therapy, end-user and regional
Based on the type, global cancer gene therapy market is segmented as:
- Gene Induced Immunotherapy
- Tumor antigen gene delivery
- Cytokine Gene Delivery
- Oncolytic Virotherapy
- Adenoviruses
- Adeno Associated Virus
- lentiviruses
- Alpha virus
- retrovirus
- Herpes simplex virus
- Vaccinia virus
- Simian virus
- Gene Transfer / Gene Replacement
- Electroporation
- Magnetofection
- Naked / Plasmid Vectors
- Gene Gun
- sonoporation
Based on the therapy, global cancer gene therapy market is segmented as:
- Retroviral Therapy
- Adenoviral Therapy
Based on the end-user, global cancer gene therapy market is segmented as:
- Hospitals
- Oncology institutes
- Biotechnological companies
- Clinical Research Labs
To view TOC of this report is available upon request @
Global cancer gene therapy market is highly fragmented with small biotech firm holding a chunk of the overall industry share. Major industry participants adopting different strategies to maintain their market positions. As per WHO, cancer incidence is projected to rise by 50% to reach 15 By the end of this decade. This growing increase in the number of patients and the effects associated with it. Small biotech firms dominate the global cancer gene therapy market than the bigger players. The players are constantly engaged in R & D in order to develop novel methods to treat various life-threatening diseases. Increased in the adoption of Emerging Genomic Technologies (NGS) and high density microarray coupled with For instance, CDC supports nationwide screening programs for the control of breast, cervical and colorectal cancer among low-income women with little or no health insurance.
Need more information about this report @
Geographically, the cancer gene therapy is segmented into North America, Europe, Latin America, Asia Pacific and the Middle East and Africa. North America leads the global cancer gene therapy market wants to boost the large pool of aging population and advances in high-tech investments in R & D activities. The UK market is expected to grow rapidly due to cancer. Asia-Pacific is expected to witness high-growth cancer growth in the healthcare market, due to increase in government initiatives, rising economy, and improvement in healthcare infrastructure in the region. Some of the key driving forces for cancer gene therapy market in emerging countries are increasing.
Some of the major companies operating in the global cancer gene therapy market are Urigen Pharmaceuticals Inc. (US), GenVec.Inc (US), Oxford BioMedica (UK), Vical (US), ANI Pharmaceuticals, Inc. (US), and Genzyme Corporation (US). Novartis AG (Switzerland), and Cell Medica (UK)
Get access to full summary @
https://www.precisionbusinessinsights.com/market-reports/global-cancer-gene-therapy-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firms, which follows a holistic approach to solve the needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and making better decisions. We provide consulting, syndicated and customized market research services based on our client needs.
Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients make business decisions.
Precision Business Insights is a company that provides agile, accurate, and actionable market insights
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): 1-866-598-1553